Legal information

This advertisement is issued by Bellevue Advisers LLP. Bellevue Advisers LLP is an appointed representative of Mirabella Advisers LLP, which is authorised and regulated by the Financial Conduct Authority. 

This advertisement is directed at professional clients and eligible counterparties as defined by the FCA in the UK only and should not be distributed to, or relied upon by persons not having professional experience in matters relating to investments, and neither Bellevue Advisers LLP nor BB Biotech AG will engage in investment activity with any such persons. This material is not intended as an offer or solicitation for the purchase or sale of shares of BB Biotech AG. 

Opinions and estimates constitute the judgement of Bellevue Asset Management and BB Biotech AG and are subject to change without notice. Past performance is not indicative of future results. This material may not be distributed within the United States or any other country where it may violate applicable law. 

Information herein is believed to be reliable, but neither Bellevue Asset Management nor BB Biotech AG guarantee its completeness or accuracy. BB Biotech AG is listed on the SIX Swiss Exchange (BION.SW), the Frankfurt Stock Exchange (BBZA.GY) and the Italian Stock Exchange (BB.IM).